📰 Trvn News
Page 4 - Trvn News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Trvn. Real-time updates on events, politics, business and more.
May 9, 2023
Trevena (NASDAQ: TRVN) announced that its partner, Jiangsu Nhwa, has received approval from China's National Medical Products Administration (NMPA) for its opioid pain medication, Olinvyk.
May 8, 2023
Trevena, Inc. (NASDAQ:TRVN – Get Rating) was the target of some unusual options trading activity on Monday. Stock investors bought 2,717 call options on the company. This is an increase of approximately 7,891% compared to the average volume of 34 call options. Trevena Stock Up 277.8 % Trevena stock traded up $1.75 during midday trading […]
May 8, 2023
Trevena, Inc. (NASDAQ:TRVN – Get Rating) was the target of some unusual options trading activity on Monday. Stock investors bought 2,717 call options on the company. This is an increase of approximately 7,891% compared to the average volume of 34 call options. Institutional Inflows and Outflows A number of hedge funds and other institutional investors […]
May 4, 2023
StockNews.com initiated coverage on shares of Trevena (NASDAQ:TRVN – Get Rating) in a research report sent to investors on Monday. The brokerage issued a sell rating on the biopharmaceutical company’s stock. A number of other research analysts have also recently commented on TRVN. JMP Securities reaffirmed a market outperform rating and issued a $2.00 target […]
May 3, 2023
Equities researchers at StockNews.com began coverage on shares of Trevena (NASDAQ:TRVN – Get Rating) in a research note issued to investors on Monday. The brokerage set a “sell” rating on the biopharmaceutical company’s stock. A number of other research firms also recently issued reports on TRVN. HC Wainwright dropped their price target on Trevena from […]
April 29, 2023
Trevena, Inc. (NASDAQ:TRVN – Get Rating) was the target of a large growth in short interest in the month of April. As of April 15th, there was short interest totalling 129,700 shares, a growth of 142.9% from the March 31st total of 53,400 shares. Based on an average daily trading volume, of 104,800 shares, the […]
April 27, 2023
StockNews.com started coverage on shares of Trevena (NASDAQ:TRVN – Get Rating) in a research note published on Sunday. The brokerage issued a sell rating on the biopharmaceutical company’s stock. Several other equities analysts have also issued reports on the stock. HC Wainwright dropped their target price on shares of Trevena from $11.00 to $9.00 and […]
April 26, 2023
StockNews.com started coverage on shares of Trevena (NASDAQ:TRVN – Get Rating) in a report issued on Sunday. The firm issued a sell rating on the biopharmaceutical company’s stock. A number of other analysts have also issued reports on TRVN. JMP Securities reiterated a market outperform rating and set a $2.00 price objective on shares of […]
April 19, 2023
StockNews.com began coverage on shares of Trevena (NASDAQ:TRVN – Get Rating) in a research report sent to investors on Saturday. The brokerage issued a sell rating on the biopharmaceutical company’s stock. Other research analysts have also issued research reports about the company. HC Wainwright lowered their price target on Trevena from $11.00 to $9.00 and […]
April 17, 2023
A number of research firms have changed their ratings and price targets for Trevena (NASDAQ: TRVN): 4/15/2023 – Trevena is now covered by analysts at StockNews.com. They set a “sell” rating on the stock. 4/4/2023 – Trevena was upgraded by analysts at StockNews.com to a “sell” rating. 3/31/2023 – Trevena had its “market outperform” rating […]